Scaffold hopping and optimisation of 3’,4’-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H

References

• UNAIDS/World Health Organization. United Nations report on 2020 Global AIDS update-seizing the moment-tackling entrenched inequalities to end epidemics. June 2020. Available from: https://www.unaids.org/sites/default/files/media_asset/2020_global-aids-report_en.pdf.
   Google Scholar
• Henderson LJ, Reoma LB, Kovacs JA, Nath A. Advances toward curing HIV-1 infection in tissue reservoirs. J Virol 2019;94:1–21.
   Web of Science ®Google Scholar
• Cohen J. Combo of two HIV vaccines fails its big test. Science 2020;367:611–2.
   PubMed Web of Science ®Google Scholar
• Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013;382:1525–33.
   PubMed Web of Science ®Google Scholar
• FDA - Approved HIV Medicines Report. Available from: https://hivinfo.nih.gov/understanding-hiv/fact-sheets/fda-approved-hiv-medicines.
   Google Scholar
• Engelman A, Cherepanov P. The structural biology of HIV-1: mechanistic and therapeutic insights. Nat Rev Microbiol 2012;10: 279–90.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Gregson J, Parkin N, et al. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. Lancet Infect Dis 2018;18:346–55.
   PubMed Web of Science ®Google Scholar
• The TenoRes Study Group. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect. Dis 2016;16:565–75.
   PubMed Web of Science ®Google Scholar
• Grandi N, Pisano MP, Scognamiglio S, et al. Comprehensive analysis of HERV transcriptome in HIV + cells: absence of HML2 activation and general downregulation of individual HERV loci. Viruses 2020;12:481.
   Web of Science ®Google Scholar
• Schatz O, Cromme FV, Naas T. Lindemann D, Mous J, Le Grice SFJ Inactivation of the RNase H domain of HIV-1 reverse transcriptase blocks viral infectivity.In: Gene Regulation and AIDS. Houston, TX: Portfolio Publishing Company; 1990,p. 293–303
   Google Scholar
• Masaoka T, Chung S, Caboni P, et al. Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H. J Med Chem 2013;56:5436–45.
   PubMed Web of Science ®Google Scholar
• Corona A, Masaoka T, Tocco G, et al. Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase. Future Med Chem 2013;5:2127–39.
   PubMed Web of Science ®Google Scholar
• Tramontano E. HIV-1 RNase H: recent progress in an exciting, yet little explored, drug target. Mini-Rev Med Chem 2006;6:727–37.
   PubMed Web of Science ®Google Scholar
• Distinto S, Maccioni E, Meleddu R, et al. Molecular aspects of the RT/drug interactions. Perspective of dual inhibitors. Curr Pharm Design 2013;19:1850–9.
   PubMed Web of Science ®Google Scholar
• Corona A, Esposito F, Tramontano E. Can the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development? Future Virol 2014;9:445–8.
   Web of Science ®Google Scholar
• Boyer PL, Smith SJ, Zhao XZ, et al. Developing and evaluating inhibitors against the RNase H active site of HIV-1 reverse transcriptase. J Virol 2018;92:1–26.
   Web of Science ®Google Scholar
• Schneider A, Corona A, Spöring I, et al. Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors. Nucleic Acids Res 2016;44:2310–22.
   PubMed Web of Science ®Google Scholar
• Corona A, Ballana E, Distinto S, et al. Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-trihydroxybenzoylhydrazone as selective inhibitor active against NNRTIs-resistant variants. Viruses 2020;12:729.
   Web of Science ®Google Scholar
• Messore A, Corona A, Madia VN, et al. Pyrrolyl pyrazoles as non-dike to acid inhibitors of the HIV-1 ribonuclease H function of reverse transcriptase. ACS Med Chem Lett 2020;11:798–805.
   PubMed Web of Science ®Google Scholar
• Xi Z, Wang Z, Sarafianos SG, et al. Determinants of active-site inhibitor interaction with HIV-1 RNase H. ACS Infect Dis 2019;5:1963–74.
   PubMed Web of Science ®Google Scholar
• Tramontano E, Corona A, Menéndez-Arias L. Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus. Antiviral Res 2019;171:104613.
   PubMed Web of Science ®Google Scholar
• Wang L, Sarafianos SG, Wang Z. Cutting into the substrate dominance: pharmacophore and structure-based approaches toward inhibiting human immunodeficiency virus reverse transcriptase-associated ribonuclease H. Acc Chem Res 2020;53:218–30.
   PubMed Web of Science ®Google Scholar
• Badland M, Compère D, Courté K, et al. Thiophene and bioisostere derivatives as new MMP12 inhibitors. Bioorg Med Chem Lett 2011; 21:528–30.
   PubMedGoogle Scholar
• Rance DJ. In: Damani LA, ed. Sulfur-containing drugs and related organic compounds, chemistry, biochemistry and toxicology: metabolism of sulfur functional groups. Vol. 1, Part B. Chichester: Ellis Horwood;1989 p. 217–68.
   Google Scholar
• Dansette PM, Bonierbale E, Minoletti C, et al. Drug-induced immunotoxicity. Eur J Drug Metab Pharmacokinet 1998;23:443–51.
   PubMed Web of Science ®Google Scholar
• Massari S, Corona A, Distinto S, et al. From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors. J Enzyme Inhib Med Chem 2019;34:55–74.
   PubMed Web of Science ®Google Scholar
• Cuzzucoli Crucitti G, Métifiot M, Pescatori L, et al. Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain. J Med Chem 2015;58:1915–28.
   PubMed Web of Science ®Google Scholar
• Ngoutane Mfopa A, Corona A, Eloh K, et al. Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions. Nat Prod Res 2018;32:640–7.
   PubMed Web of Science ®Google Scholar
• Tintori C, Corona A, Esposito F, et al. Inhibition of HIV-1 reverse transcriptase dimerization by small molecules. ChemBioChem 2016;17:683–8.
   PubMed Web of Science ®Google Scholar
• Tocco G, Begala M, Esposito F, et al. ZnO-mediated regioselective C-arylsulfonylation of indoles: a facile solvent-free synthesis of 2- and 3-sulfonylindoles and preliminary evaluation of their activity against drug-resistant mutant HIV-1 reverse transcriptases (RTs). Tetrahedron Lett 2013;54:6237–41.
   Web of Science ®Google Scholar
• Corona A, Di Leva FS, Thierry S, et al. Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives. Antimicrob Agents Chemother 2014;58:6101–10.
   PubMed Web of Science ®Google Scholar
• Virgilio A, Amato T, Petraccone L, et al. Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops. Sci Rep 2018;8:7447.
   PubMed Web of Science ®Google Scholar
• Tintori C, Esposito F, Morreale F, et al. Investigation on the sucrose binding pocket of HIV-1 integrase by molecular dynamics and synergy experiments. Bioorg Med Chem Lett 2015;25:3013–6.
   PubMed Web of Science ®Google Scholar
• Esposito F, Tintori C, Martini R, et al. Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation. ChemBioChem 2015;16:2507–12.
   PubMed Web of Science ®Google Scholar
• Esposito F, Sechi M, Pala N, et al. Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors. Antiviral Research 2020;174:104671.
   PubMed Web of Science ®Google Scholar
• Sala M, Spensiero A, Esposito F, et al. Development and identification of a novel anti-HIV-1 peptide derived by modification of the N-terminal domain of HIV-1 integrase. Front Microbiol 2016;845:1–9.
   Google Scholar
• Esposito V, Esposito F, Pepe A, et al. Probing the importance of the G-quadruplex grooves for the activity of the anti-HIV-integrase aptamer T30923. Int J Mol Sci 2020;21:5637.
   Web of Science ®Google Scholar
• Pisano MB, Cosentino S, Viale S, et al. Biological activities of aerial parts extracts of euphorbia characias. Biomed Res Int 2016;2016:1538703.
   PubMed Web of Science ®Google Scholar
• Corona A, Onnis V, Del Vecchio C, et al. 2-(Arylamino)-6-(trifluoromethyl)nicotinic acid derivatives: new HIV-1 RT dual inhibitors active on viral replication. Molecules 2020;25:1338.
   Web of Science ®Google Scholar
• Esposito F, Sanna C, Del Vecchio C, et al. Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities. Pathog Dis 2013;68:116–24.
   PubMed Web of Science ®Google Scholar
• Desantis J, Massari S, Corona A, et al. 1,2,4-Triazolo[1,5-a]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-associated Ribonuclease H activity. Molecules 2020;25:1183.
   Web of Science ®Google Scholar
• Nettleship JE, Brown J, Groves MR, Geerlof A. Methods for protein characterization by mass spectrometry, thermal shift (ThermoFluor) assay, and multiangle or static light scattering. Methods Mol Biol 2008;426:299–318.
   PubMedGoogle Scholar
• Yonetani T. The Yonetani-Theorell graphical method for examining overlapping subsites of enzyme active centers. Methods Enzymol 1982;87:500–9.
   PubMed Web of Science ®Google Scholar
• Sonar VP, Corona A, Distinto S, et al. Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase. Eur J Med Chem 2017;130:248–60.
   PubMed Web of Science ®Google Scholar
• Weislow OS, Kiser R, Fine DL, et al. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 1989; 81:577–86.
   PubMed Web of Science ®Google Scholar
• Bakavoli M, Bagherzadeh G, Vaseghifar M, et al. Iodine catalysed synthesis and antibacterial evaluation of thieno[2,3-d]pyrimidine derivatives. J Chem Res 2009;2009:653–5.
   Google Scholar
• Raffa D, Maggio B, Plescia F, et al. Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides. Eur J Med Chem 2011; 46:2786–96.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Bian M, Deng X, et al. Synthesis and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amines. Arch Pharm Chem Life Sci 2013;346:119–26.
   PubMed Web of Science ®Google Scholar
• Del Zotto A, Amoroso F, Baratta W, Rigo P. Very fast suzuki–miyaura reaction catalyzed by Pd(OAc)2 under aerobic conditions at room temperature in EGME/H2O. Eur J Org Chem 2008;2009:110–6.
   Web of Science ®Google Scholar
• Roussaki M, Kontogiorgis CA, Hadjipavlou-Litina D, et al. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity. Bioorg Med Chem Lett 2010;20:3889–92.
   PubMed Web of Science ®Google Scholar
• Chung S, Miller JT, Johnson BC, et al. Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity. J Biol Chem 2012;287:4066∓75.
   PubMed Web of Science ®Google Scholar
• Dubey S, Satyanarayana YD, Lavania H. Development of integrase inhibitors for treatment of AIDS: an overview. Eur J Med Chem 2007;42:1159–68.
   PubMed Web of Science ®Google Scholar
• Esposito F, Tramontano E. Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors. Antiv Chem Chemother 2014;23:129–44.
   PubMedGoogle Scholar
• Cummings MD, Farnum M, Nelen MI. Universal screening methods and applications of ThermoFluor. J Biomol Screen 2006;11:854–63.
   PubMed Web of Science ®Google Scholar
• Himmel DM, Sarafianos SG, Dharmasena S, et al. HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site. ACS Chem Biol 2006;1:702–12.
   PubMed Web of Science ®Google Scholar
• Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 2010;53:2719–40.
   PubMed Web of Science ®Google Scholar
• Ingólfsson HI, Thakur P, Herold KF, et al. Phytochemicals perturb membranes and promiscuously alter protein function. ACS Chem Biol 2014;9:1788–9178.
   PubMed Web of Science ®Google Scholar